Previous 10 | Next 10 |
IRVINE, Calif., April 06, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today congratulates uniQure N.V. on the early completion of patient enrollment i...
Potential for 100 gene therapy trials to be using ClearPoint. Expect significant growth in 2H 2021 as elective surgeries rebound and clinical trials restart. Recent expansion to Europe augurs well for European biologics partners. We see potential for $100M+ revenues and 30%+ n...
Image source: The Motley Fool. ClearPoint Neuro Inc. Common Stock (NASDAQ: CLPT) Q4 2020 Earnings Call Mar 04, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: ClearPoint Neuro Inc. Common Stock (CLPT) Q4 2020 Earnin...
Clearpoint Neuro, Inc. (CLPT) Q4 2020 Earnings Conference Call March 04, 2021, 16:30 ET Company Participants Joseph Burnett - President, CEO & Director Danilo D’Alessandro - CFO Conference Call Participants Andrew D'Silva - B. Riley Securities Frank Takkinen - Lake Street Capital M...
ClearPoint Neuro (CLPT): Q4 GAAP EPS of -$0.09 misses by $0.01.Revenue of $3.72M (+15.9% Y/Y) beats by $0.01M.Press Release For further details see: ClearPoint Neuro EPS misses by $0.01, beats on revenue
Company Reports Record Revenues IRVINE, Calif., March 04, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced financial results for it...
ClearPoint Neuro (CLPT) announced the closing of its previously disclosed public offering of 2.12M shares, with expected gross proceeds of about $46.8M.The company will use the net proceeds from the offering to fund product development and research and development activities and th...
IRVINE, Calif., Feb. 23, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced the closing of its previously disclosed public offering of common...
IRVINE, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it will release financial results for its 2020 fourth quarte...
ClearPoint Neuro (CLPT) has priced its public offering of ~1.85M common shares at $23.50/share.Underwriters' over-allotment is an additional 277.52K shares. Net proceeds will be used to fund product development, for R&D activities, working capital and general corporate purposes.Closing da...
News, Short Squeeze, Breakout and More Instantly...
ClearPoint Neuro, Inc. Company Name:
CLPT Stock Symbol:
NASDAQ Market:
ClearPoint Neuro, Inc. Website:
SOLANA BEACH, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced that it will release financial results for its ...
2024-07-15 17:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...